Serious side effects, including aortic aneurysm and long-term nerve damage, have been associated with a class of antibiotics called fluoroquinolones. Accordingly, the FDA has strengthened label warnings for bacteria-fighting drugs such as Levaquin and Avelox.
The FDA has reported concerns about Levaquin and Avelox since 2008. However, it wasn’t until 2015 that an FDA advisory committee cautioned that fluoroquinolones shouldn't be prescribed for chronic bronchitis, sinusitis, or urinary tract infections.
Dr. Edward Cox, the director of the Office of Antimicrobial Products at the FDA, said "fluoroquinolones have risks and benefits that should be considered very carefully.”
In a statement released to CBS News, Dr. Cox elaborates on the possibility of the potentially permanent side effects of Levaquin and Avelox. These adverse effects involve muscles, tendons, joints, nerves and the central nervous system, and can occur hours or weeks after exposure to fluoroquinolone pills or injections. It should also be noted that two or more serious side effects can occur together.
If you or a loved one has taken Levaquin or Avelox and suffered an aortic aneurysm or an aortic dissection, it’s important to be aware of the potential side effects and your rights. If you have immediate medical concerns, consult with your primary physician.
The Law Offices of Foster & Houston will continue to share important news involving fluoroquinolones to help you stay informed. You can learn more about Levaquin and Avelox by visiting our website or dialing (877) 377-5411.
Source: CBS News
Additional Levaquin and Avelox Resources:
- How to Know if You Have an Avelox or Levaquin Lawsuit
- Blog: FDA Calls for Restricted Use of Levaquin and Avelox
- Blog: Warnings About Levaquin and Avelox Strengthened by FDA